Perco, Paul
Innsbruck Medical University · Universität Innsbruck
4 papers on CoChatORCID 0000-0003-2087-5691
Most cited papers
- Verified
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Heerspink, H. J. L., Perco, P., Mulder, S., Leierer, J., Hansen, M. K., Heinzel, A., & Mayer, G. (2019) · Diabetologia
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 457
- Verified
Association of the COVID-19 pandemic with internet search volumes: a Google Trends™ analysis
Effenberger, M., Kronbichler, A., Shin, J. I., Mayer, G., Tilg, H., & Perco, P. (2020) · International Journal of Infectious Diseases
Data-Driven Disease SurveillanceCOVID-19 epidemiological studies
Cited by 270
- Verified
Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation
Koppelstaetter, C., Schratzberger, G., Perco, P., Hofer, J., Mark, W., Öllinger, R., Oberbauer, R., Schwarz, C., Mitterbauer, C., Kainz, A., et al. (2008) · Aging Cell
Telomeres, Telomerase, and SenescenceRenal Transplantation Outcomes and Treatments
Cited by 124
- Verified
Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy
Fechete, R., Heinzel, A., Perco, P., Mönks, K., Söllner, J., Stelzer, G., Eder, S., Lancet, D., Oberbauer, R., Mayer, G., et al. (2011) · PROTEOMICS – Clinical Applications
Bioinformatics and Genomic NetworksChronic Kidney Disease and Diabetes
Cited by 45
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free